Get started
RocketTickers

Ultragenyx Announces Positive Topline Results

Long
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)  
RocketTickers  
NASDAQ:RARE   Ultragenyx Pharmaceutical Inc.
Beyond Technical Analysis
1
0
beyondta
RARE: Ultragenyx Pharmaceutical Inc.
2019-01-04 08:30:00
Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.